Ageon LongevityGet your biological age
CardioModerate evidence · 4 sources

Zone 2, the easy cardio you can talk through

Steady cardio at a pace where you can still chat. It counts toward the exercise that adds years, but it isn't magic.

Zone 2 is steady cardio at an effort where you can still hold a conversation. For most people that's a brisk walk uphill, an easy jog or a relaxed bike ride. In a lab it's the effort just below the point where lactate starts building up in your blood. Outside a lab, heart rate is the usual stand-in.

The case for moderate cardio is strong. The WHO recommends 150 to 300 minutes a week for adults. A pooled analysis of 661,137 adults found that people who met the 150-minute minimum were 31% less likely to die over 14 years than people who did no exercise in their free time. Doing three to five times that much raised the figure to 39%. The first 150 minutes do most of the work.

The case for zone 2 in particular is weaker. Its popularity comes from elite endurance athletes, who train huge volumes at that intensity. A 2025 review found no evidence that zone 2 beats harder exercise for fitness or for your mitochondria. With only a few hours a week, harder sessions seem to give more fitness per minute. Zone 2 is still a good base because it's easy to recover from and easy to stick with. Add some harder efforts if you can.

Ageon counts a zone 2 day when your watch records at least 20 minutes of workouts at 60 to 70% of your maximum heart rate. It estimates your maximum as 208 minus 0.7 times your age, a formula from a study of over 18,000 people. Your real maximum may differ.

A zone 2 day earns 3 points, the most a habit can earn, because it's moderate cardio and the evidence for moderate cardio is strong. This article is tagged moderate because the evidence that zone 2 beats other cardio isn't.

Sources

  1. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Bull et al., British Journal of Sports Medicine, 2020.
  2. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship. Arem et al., JAMA Internal Medicine, 2015.
  3. Much ado about zone 2: a narrative review assessing the efficacy of zone 2 training. Storoschuk et al., Sports Medicine, 2025.
  4. Age-predicted maximal heart rate revisited. Tanaka et al., Journal of the American College of Cardiology, 2001.